O-GlcNAc modification is associated with insulin sensitivity in the whole blood of healthy young adult males

Diabetology and Metabolic Syndrome

Volumn 6, Issue 1, 2014, Pages

  Myslicki, Jason P ^a   Shearer, Jane ^a   Hittel, Dustin S ^a   Hughey, Curtis C ^a   Belke, Darrell D ^a  

^a UNIVERSITY OF CALGARY   (Canada)

Author keywords

HOMA IR; Insulin resistance; Metabolism; Obesity; Young adult

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN; INSULIN; N ACETYLGLUCOSAMINE; O LINKED BETA N ACETYLGLUCOSAMINE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ADULT; ANTHROPOMETRY; ARTICLE; BLOOD SAMPLING; BODY FAT; BODY MASS; CLINICAL ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FITNESS; GLUCOSE BLOOD LEVEL; HUMAN; IMMUNOBLOTTING; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; METABOLIC PARAMETERS; OUTCOME ASSESSMENT; PROTEIN EXPRESSION; PROTEIN MODIFICATION; TRIACYLGLYCEROL BLOOD LEVEL; YOUNG ADULT;

EID: 84907050536     PISSN: None     EISSN: 17585996     Source Type: Journal    
DOI: 10.1186/1758-5996-6-96     Document Type: Article

References (19)

1. National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Danaei G, Finucane MM, Lu Y, Singh GM, Cowan MJ, Paciorek CJ, Lin JK, Farzadfar F, Khang YH, Stevens GA, Rao M, Ali MK, Riley LM, Robinson CA, Ezzati M, Lancet 2011 378 31 40
2. Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa heart study. Berenson GS, Srinivasan SR, Bao W, 3rd Newman WP, Tracy RE, Wattigney WA, N Engl J Med 1998 338 1650 1656
3. Comparison of A1C and fasting glucose criteria to diagnose diabetes among U.S. adults. Carson AP, Reynolds K, Fonseca VA, Muntner P, Diabetes Care 2010 33 95 97
4. Site-specific GlcNAcylation of human erythrocyte proteins: potential biomarker(s) for diabetes. Wang Z, Park K, Comer F, Hsieh-Wilson LC, Saudek CD, Hart GW, Diabetes 2009 58 309 317
5. O-GlcNAc modification, insulin signaling and diabetic complications. Issad T, Masson E, Pagesy P, Diabetes Metab 2010 36 423 435
6. Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3 T3-L1 adipocytes. Vosseller K, Wells L, Lane MD, Hart GW, Proc Natl Acad Sci U S A 2002 99 5313 5318
7. Increased expression of beta-N-acetylglucosaminidase in erythrocytes from individuals with pre-diabetes and diabetes. Park K, Saudek CD, Hart GW, Diabetes 2010 59 1845 1850
8. Exploring leukocyte O-GlcNAcylation as a novel diagnostic tool for the earlier detection of type 2 diabetes mellitus. Springhorn C, Matsha TE, Erasmus RT, Essop MF, J Clin Endocrinol Metab 2012 97 4640 4649
9. Effect of the SORT1 low-density lipoprotein cholesterol locus is sex-specific in a fit, Canadian young-adult population. Karlos A, Shearer J, Gnatiuk E, Onyewu C, Many G, Hoffman EP, Hittel DS, Appl Physiol Nutr Metab 2013 38 188 193
10. Exercise training mitigates aberrant cardiac protein O-GlcNAcylation in streptozotocin-induced diabetic mice. Bennett CE, Johnsen VL, Shearer J, Belke DD, Life Sci 2013 92 657 663
11. Enhanced cardiac protein glycosylation (O-GlcNAc) of selected mitochondrial proteins in rats artificially selected for low running capacity. Johnsen VL, Belke DD, Hughey CC, Hittel DS, Hepple RT, Koch LG, Britton SL, Shearer J, Physiol Genomics 2013 45 17 25
12. Co-relations and their measurement, chielfy from anthropometric data. Galton F, Proc Roy Soc London 1888 45 135 145
13. Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R, Diabetes Care 2003 26 3320 3325
14. Isoenzyme pattern and partial characterization of hexosaminidases in the membrane and cytosol of human erythrocytes. Massaccesi L, Lombardo A, Venerando B, Tettamanti G, Goi G, Clin Biochem 2007 40 467 477
15. Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Stehouwer CD, Henry RM, Ferreira I, Diabetologia 2008 51 527 539
16. O-GlcNAc signaling: a metabolic link between diabetes and cancer? Slawson C, Copeland RJ, Hart GW, Trends Biochem Sci 2010 35 547 555
17. Spliced X-box binding protein 1 couples the unfolded protein response to hexosamine biosynthetic pathway. Wang ZV, Deng Y, Gao N, Pedrozo Z, Li DL, Morales CR, Criollo A, Luo X, Tan W, Jiang N, Lehrman MA, Rothermel BA, Lee AH, Lavandero S, Mammen PP, Ferdous A, Gillette TG, Scherer PE, Hill JA, Cell 2014 156 1179 1192
18. Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3 T3-L1 adipocytes. Whelan SA, Dias WB, Thiruneelakantapillai L, Lane MD, Hart GW, J Biol Chem 2010 285 5204 5211
19. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Wells L, Vosseller K, Hart GW, Cell Mol Life Sci 2003 60 222 228